CClinicalTrials.gg
TerminatedNCT05173870Updated Apr 13, 2026

Remote Monitoring to Prevent Frailty Progression in the Elderly

An observational study in Frailty, Elderly and Wearable Device, sponsored by Neuromed IRCCS. Terminated at 2 sites in Italy. Open to participants aged 65 Years and older. Per ClinicalTrials.gov, last updated 2026-04-13.

Sponsored by Neuromed IRCCS · Observational

Why this study was terminated
The partecipation rate was very low
Study type
Observational
Model
Other
Time perspective
Prospective
Enrollment
30
Ages
65 Years and older
Sex
All
01

Study summary

Frailty is a frequent condition in elderly, characterized by reduced physiologic reserve, leading to an increased risk for adverse events, such as disability, hospitalization, and death. In particular, it is a multidimensional disfunctional condition, including decreases in physiologic capacity in neurologic control (indicated by diminished ability to perform complex tasks), mechanical performance (e.g. diminished strength), and energy metabolism (e.g. decreased aerobic status due to cardiac or pulmonary diseases or both). All these factors lead to the worsening of quality of life. Focusing on the great impact of this condition in global population and the rising of social/health costs, related to this condition, frailty is earning a great interest from both at political level and European Community. For this reason, developing interventions programs aiming to prevent the progression of frailty towards the independence loss, it is considered a key objective for the improvement of the quality of life. In this context, this pilot study looks at the standardization of a study protocol to develop a useful model for enhancing local care in small population isolates, by remotely monitoring the health status of pre-frail subjects and improving the progression of the frailty condition, in order to support a healthy ageing for future investigation including a larger number of individuals.

Read the detailed description

Frailty is a condition of increased vulnerability to stressors due to age-related declines in physiologic reserves across neuromuscular, metabolic, and immune systems. It is considered a medical geriatric syndrome with multiple causes and contributors and it is characterized by diminished strength, power and endurance. In general, therefore, frailty is considered to be a multifactorial dysfunctional framework which includes the physical, psychological, cognitive, economic and social spheres and which leads to a serious deterioration in the quality of life. Due to the great impact of this condition on quality of life, developing interventions programs aiming to prevent the progression of frailty towards the independence loss, it is considered a key objective to support an healthy ageing.

In this context, the primary aim of the present pilot study is to standardize a study protocol to develop a useful model to enhance local care in small population isolates, by remotely monitoring the health status of pre-frail subjects and to improve the progression of the frailty condition, in order to support a healthy ageing for future investigation including a larger number of individuals.

Additional aims:

  • To quantify the timeframes necessary for the subjects recruiting and examination activities,including questionnaires and functional tests administration;
  • To quantify the training time needed to explain the use of the wearable device to the recruited elderly individuals;
  • To assess the responsiveness of pre-frail subjects, during the preliminary screening, the examination visit and the monitoring period (follow-up 6 months);
  • To evaluate the compliance of pre-frail individuals with the use of the wearable device.

All men and women aged >= 65 years, resident a small mountain village (Salcito) in Molise region, Italy, will be invited to participate at the first examination, in order to evaluate their frailty condition, in a specific way their pre-frail/frail condition.

In the screening phase, in particular, it will be used the AGILE score to select the subjects to be included in the study. The questionnaire is a frailty tool that allows to quickly identify elderly, but also to investigate "multidimensional" frailty. It is built by selecting among the 40 items of the italian frailty index, the 10 ones most predictive of mortality. Therefore the questionnaire is composed by 10 items with a dychotomous answer (yes/no), in order to homogenously represent the four domains of frailty: physical, mental, nutrirional and socio-economic. After the preliminary screening, 30 elderly with pre-frailty will be randomly selected to be equipped with the wearable devices (such as smartband and smart-clothes ).The wearable devices have a biosensor able to daily collect,in a remote way, many biometric measurements such as: blood pressure, body temperature, heart and respiratory rate, posture and sleep quality.

During the baseline visit, the 30 pre-frail elderly will be trained to the use of the wearable devices. In addition, others questionnaires will be administered to collect information on their dietary habits, lifestyles, cognitive assessment and clinical history of the major chronic disease (CVD, cancer…). Additionally, during the baseline visit of recruited 30 pre-frail subjects, a venous blood sample will be collected. This will be used to measure biochemical and molecular parameters. In particular, samples will be analyzed to study potential biomarkers of pre-frailty/frailty condition. An aliquot of the biological sample will be stored in liquid nitrogen in a dedicated biobank of IRCCS (Istituto di Ricovero e Cura a Carattere Scientifico) NEUROMED, for any future molecular analysis.

Thanks to the wearable devices, individuals will be monitored constantly for six months, from a health point of view.

In the early stages of recruitment it will be possible to identify any critical issues in the training procedures of individuals over 65 recruited to use the wearable device.

During the six months period of monitoring, it will be possible to evaluate the compliance of subjects recruited to the wearable device use. In particular, it could be possible to evaluate the reliability of collected data thanks to the device and eventually make changes in operative procedures, when needed. If, during the monitoring, an abnormal parameter value will be observed, it will be communicated both to the subject and to his physician, with the aim of promoting a greater attention to personal health. In this way it could be possible to ensure a better quality of life. During six months, participants will be called back every other month, in order to evaluate the status of devices. After six months, participants will be called back for a follow-up visit, during which all the test, the questionnaires and the blood sample collection will be repeated to evaluate the potential impact of monitoring, on their condition.

02

Conditions studied

  • Frailty
  • Elderly
  • Wearable Device

Browse trials for

Keywords

  • Frailty
  • Wearable device
  • Elderly
  • Health status monitoring
03

In context

Frailty

1,199 studies on the registry are indexed under Frailty; 430 are open to participants now.

This study's enrollment of 30 is below the median of 223 across 496 observational studies indexed under Frailty.

Browse Frailty studies →

Lead sponsor

Neuromed IRCCS is the lead sponsor of 76 studies on the registry; 23 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
65 Years and older
Sexes eligible
All
Sampling method
Probability sample

Study population

All men and women aged >= 65 years, resident in Salcito, a small mountain village in Molise region, Italy, will be invited to participate at the first examination, in order to evaluate their frailty condition, in a specific way their pre-frail/frail condition.

Inclusion criteria

  • Diagnosis of Pre-Frail;
  • Salcito (a small mountain village in Molise region) residents.

Exclusion criteria

Exclusion Criteria:

  • Age\< 65 years;
  • Individuals affected by physical or mental diseases, pacemaker or other medical device keeper who make the use of "wearable device" not possible or unable to complete functional tests.
05

Study design

Observational model
Other
Time perspective
Prospective
Enrollment
30 participants (actual)
Patient registry
No
Biospecimen retention
Samples with dna

Interventions

  • DeviceWearable device

    The wearable devices has a biosensor able to daily collect,in a remote way, many biometric measurements such as: blood pressure, blood oxygenation, heart and respiratory rate

06

What researchers measure

Primary outcomes

  1. Study protocol assessment

    To standardize a study protocol to develop a useful model for enhancing local care in small population isolates, by remotely monitoring the health status of pre-frail subjects and improving the progression of the frailty condition in order to support a healthy ageing for future investigation including a larger number of individuals.

    Time frame: From February 2022 to August 2023

Secondary outcomes

  1. Recruitment phase

    This pilot study will be performed to quantify the timeframes necessary for the recruitment of the elderly subjects and for the examination activities, including questionnaires and functional tests administration.

    Time frame: From February 2022 to May 2022

  2. Training Phase

    This pilot study will be performed to quantify the training time needed to explain the use the wearable device to the recruited elderly individuals.

    Time frame: From February 2022 to May 2022

  3. Pre-frail subjects responsiveness

    This pilot study want to assess the responsiveness (i.e.the active participation to the project) of pre-frail subjects. This aspect will be evaluated as follows: 1. Affirmative response to the invitation to the screeening visit; 2. Active participation and complete all the questionnaires during the examination visit; 3. Collaboration and interactions with the researchers during the monitoring period (follow-up 6 months).

    Time frame: From February 2022 to August 2022

  4. Wearable device compliance

    This pilot study want to evaluate the compliance of pre-frail individuals with the use of the wearable device. This aspect will be evaluated by monitoring the time during which subjects wear the device. If it is weared less than 5 days (20/24h) per week, it will be considered as a low compliance.

    Time frame: From February 2022 to August 2022

07

Study locations

2 sites
  • IRCCS INM Neuromed, Department of Epidemiology and Prevention
    Pozzilli, IS 86077, Italy
  • IRCCS Neuromed
    Pozzilli, IS 86077, Italy
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Apr 13, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT05173870
Lead sponsor
Neuromed IRCCS
Collaborators
University of Molise
Responsible party
Licia Iacoviello (Head of the Department of Epidemiology and Prevention, Neuromed IRCCS) — Principal investigator
First posted
Dec 30, 2021
Start date
Jun 1, 2023
Primary completion
May 31, 2024
Completion
Jul 31, 2024
Last update
Apr 13, 2026

Study contacts

Licia Iacoviello, MD, PhD
principal investigator · IRCCS Neuromed

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is terminated, as verified in Apr 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion